A systematic review on the role of fish oil for the treatment of cachexia in advanced cancer: An EPCRC cachexia guidelines project

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Palliative Medicine

• Publication date

  2012-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1177/0269216311418709PMID 21865295
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Definition and classification of cancer cachexia: an international consensus.

  2011cited by this paper
• Consensus on cachexia definitions.

  2010cited by this paper
• Marine phospholipids—a promising new dietary approach to tumor-associated weight loss

  2010cited by this paper
• Anorexia-cachexia syndrome: a systematic review of the role of dietary polyunsaturated Fatty acids in the management of symptoms, survival, and quality of life.

  2009cited by this paper
• Enteral Nutrition Enriched With Eicosapentaenoic Acid (EPA) Preserves Lean Body Mass Following Esophageal Cancer Surgery: Results of a Double-Blinded Randomized Controlled Trial

  2009cited by this paper
• Enteral Nutrition During Multimodality Therapy in Upper Gastrointestinal Cancer Patients

  2009cited by this paper
• Symptom assessment in palliative care: a need for international collaboration.

  2008cited by this paper
• Immunoenhanced enteral nutrition formulas in head and neck cancer surgery: a prospective, randomized clinical trial.

  2008cited by this paper
• Randomized phase III clinical trial of five different arms of treatment for patients with cancer cachexia: interim results.

  2008cited by this paper
• A randomized clinical trial with two omega 3 fatty acid enhanced oral supplements in head and neck cancer ambulatory patients.

  2008cited by this paper
• N-3 fatty acids, cancer and cachexia: a systematic review of the literature.

  2007cited by this paper
• Nutrition intervention using an eicosapentaenoic acid (EPA)-containing supplement in patients with advanced colorectal cancer. Effects on nutritional and inflammatory status: a phase II trial

  2007cited by this paper
• Eicosapentaenoic acid (EPA, an omega-3 fatty acid from fish oils) for the treatment of cancer cachexia.

  2007cited by this paper
• A Phase II Study with Antioxidants, Both in the Diet and Supplemented, Pharmaconutritional Support, Progestagen, and Anti-Cyclooxygenase-2 Showing Efficacy and Safety in Patients with Cancer-Related Anorexia/Cachexia and Oxidative Stress

  2006cited by this paper
• Favorable Effects of Preoperative Enteral Immunonutrition on a Surgical Site Infection in Patients with Colorectal Cancer Without Malnutrition

  2006cited by this paper
• Double-blind, placebo-controlled, randomized study of eicosapentaenoic acid diester in patients with cancer cachexia.

  2006cited by this paper
• Systems for grading the quality of evidence and the strength of recommendations II: Pilot study of a new system

  2005cited by this paper
• The Clinical Value of Parenteral Immunonutrition in Surgical Patients

  2005cited by this paper
• Compliance with nutrition prescription improves outcomes in patients with unresectable pancreatic cancer.

  2005cited by this paper
• Effect of early postoperative enteral immunonutrition on wound healing in patients undergoing surgery for gastric cancer.

  2005cited by this paper
• Nutrition intervention improves outcomes in patients with cancer cachexia receiving chemotherapy—a pilot study

  2005cited by this paper
• Impact of fish oil and melatonin on cachexia in patients with advanced gastrointestinal cancer: a randomized pilot study.

  2005cited by this paper
• A pilot study on safety and pharmacokinetics of infliximab for the cancer anorexia/weight loss syndrome in non-small-cell lung cancer patients

  2004cited by this paper
• Phase II study of high‐dose fish oil capsules for patients with cancer‐related cachexia

  2004cited by this paper
• Bioelectrical impedance analysis-part II: utilization in clinical practice.

  2004cited by this paper
• An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: a North Central Cancer Treatment Group and National Cancer Institute of Canada collaborative effort.

  2004cited by this paper
• Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with n-3 fatty acids

  2004cited by this paper
• Modulation of the liver export protein synthetic response to feeding by an n-3 fatty-acid-enriched nutritional supplement is associated with anabolism in cachectic cancer patients.

  2004cited by this paper
• Investigating the utility of serum cytokine measurements in a multi-institutional cancer anorexia/weight loss trial

  2004cited by this paper
• Cancer-related anorexia/cachexia syndrome and oxidative stress: an innovative approach beyond current treatment.

  2004cited by this paper
• Effect of Fish Oil on Appetite and Other Symptoms in Patients with Advanced Cancer and Anorexia/Cachexia: A Double-Blind, Placebo-Controlled Study

  2003influential reference
• Effect of fish oil on appetite and other symptoms in patients with advanced cancer and anorexia/cachexia: a double-blind, placebo-controlled study.

  2003cited by this paper
• Effect of a protein and energy dense n-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial

  2003cited by this paper
• Nutritional approach in malnourished surgical patients: a prospective randomized study.

  2002cited by this paper
• Tolerance and incorporation of a high-dose eicosapentaenoic acid diester emulsion by patients with pancreatic cancer cachexia

  2001cited by this paper
• Effect of a Fish Oil-Enriched Nutritional Supplement on Metabolic Mediators in Patients With Pancreatic Cancer Cachexia

  2001cited by this paper
• Metabolic response to feeding in weight-losing pancreatic cancer patients and its modulation by a fish-oil-enriched nutritional supplement.

  2000cited by this paper
• Eicosapentaenoic acid ethyl ester supplementation in cachectic cancer patients and healthy subjects: effects on lipolysis and lipid oxidation.

  2000influential reference
• Effect of Oral Eicosapentaenoic Acid on Weight Loss in Patients With Pancreatic Cancer

  2000cited by this paper
• The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer

  1999cited by this paper
• Phase I clinical study of fish oil fatty acid capsules for patients with cancer cachexia: cancer and leukemia group B study 9473.

  1999influential reference
• Fish oil-enriched nutritional supplement attenuates progression of the acute-phase response in weight-losing patients with advanced pancreatic cancer.

  1999cited by this paper
• Dietary omega‐3 polyunsaturated fatty acids plus vitamin E restore immunodeficiency and prolong survival for severely ill patients with generalized malignancy

  1998cited by this paper
• Down-regulation of the acute-phase response in patients with pancreatic cancer cachexia receiving oral eicosapentaenoic acid is mediated via suppression of interleukin-6.

  1997cited by this paper
• Effect of a fish oil structured lipid-based diet on prostaglandin release from mononuclear cells in cancer patients after surgery.

  1997cited by this paper
• Immune and nutritional effects of early enteral nutrition after major abdominal operations.

  1996cited by this paper
• Early enteral feeding in postsurgical cancer patients. Fish oil structured lipid-based polymeric formula versus a standard polymeric formula.

  1996cited by this paper
• The effect of polyunsaturated fatty acids on the progress of cachexia in patients with pancreatic cancer.

  1996cited by this paper
• Enteral Nutrition During Multimodality Therapy in Upper Gastrointestinal Cancer Patients

  1995cited by this paper

• Prognostic Significance of Sarcopenia and Eicosapentaenoic Acid (EPA) Levels in Patients With Unresectable Pancreatic or Biliary Tract Cancer.

  2024cites this paper
• Advancing cancer cachexia diagnosis with -omics technology and exercise as molecular medicine

  2024cites this paper
• Updates in Cancer Cachexia: Clinical Management and Pharmacologic Interventions

  2024cites this paper
• Relevance of Dietary Supplement Use in Gastrointestinal-Cancer-Associated Cachexia

  2023cites this paper
• Nutritional Approach to Cancer Cachexia: A Proposal for Dietitians

  2022cites this paper
• Pathophysiology of cachexia and characteristics of dysphagia in chronic diseases

  2022cites this paper
• Posicionamento BRASPEN sobre o uso clínico de ômega 3 via parenteral

  2022cites this paper
• Tumor cell anabolism and host tissue catabolism-energetic inefficiency during cancer cachexia

  2022cites this paper
• Omega-3 Fatty Acid and its Protective Effect against Cancer and Cancer-related Complication

  2022cites this paper
• Chia seeds (Salvia hispanica L.): A therapeutic weapon in metabolic disorders

  2022cites this paper
• Omega-3 polyunsaterated fatty acids improve quality of life and survival, but not body weight in cancer cachexia: A systematic review and meta-analysis of controlled trials.

  2022cites this paper
• Oxidative stress and cancer: Role of n-3 PUFAs

  2021cites this paper
• N-3 fatty acid EPA supplementation in cancer patients receiving abdominal radiotherapy - A randomised controlled trial.

  2021cites this paper
• [Cachexia - A Cluster of Losses].

  2021cites this paper
• Cancer Cachexia

  2021cites this paper
• Cancer Cachexia: Definition, Staging, and Emerging Treatments

  2020cites this paper
• Expert Opinion on Benefits of Long-Chain Omega-3 Fatty Acids (DHA and EPA) in Aging and Clinical Nutrition

  2020cites this paper
• Integrating Traditional and Complementary Medicine Recommendations into Clinical Practice Guidelines for People with Diabetes in Need of Palliative and End-of-Life Care: A Scoping Review

  2020cites this paper
• Management of Cancer Cachexia: ASCO Guideline.

  2020cites this paper
• Aktualisierte S3-Leitlinie „Palliativmedizin für Patienten mit einer nicht heilbaren Krebserkrankung“

  2020cites this paper
• Advances in Immunonutrient Application to Treat Cancer Cachexia Syndrome

  2020cites this paper
• CMAR_A_261585 5597..5605

  2020cites this paper
• Nutritional management in cancer patients with SARS-CoV-2infection

  2020cites this paper
• The effect of oral omega-3 polyunsaturated fatty acid supplementation on muscle maintenance and quality of life in patients with cancer: A systematic review and meta-analysis.

  2020cites this paper
• Quercetin supplementation attenuates muscle wasting in cancer-associated cachexia in mice

  2020cites this paper
• Transplant-Related Non-pain Issues: Prevention, Intervention, and Limitations

  2020cites this paper
• Impact of Early Incorporation of Nutrition Interventions as a Component of Cancer Therapy in Adults: A Review

  2020cites this paper
• Роль нутритивной поддержки в лечении пациентов онкологического профиля, инфицированных SARS-CoV-2

  2020cites this paper
• Sip feeding as a type of nutritional and metabolic support in clinical medicine

  2020cites this paper
• Cancer cachexia and skeletal muscle atrophy in clinical studies: what do we really know?

  2020cites this paper
• Supportive Care Strategies: Optimizing Transplant Care

  2020cites this paper
• Cachexia/Anorexia and Feeding Difficulties

  2019cites this paper
• Protective Effects of Omega-3 Fatty Acids in Cancer-Related Complications

  2019cites this paper
• The role of omega 3 fatty acids in suppressing muscle protein catabolism: A possible therapeutic strategy to reverse cancer cachexia?

  2019cites this paper
• Therapeutic strategies against cancer cachexia

  2019cites this paper
• Combination therapy in cachexia.

  2019cites this paper
• Skeletal Muscle Wasting: Clinical implications and experimental treatment

  2019cites this paper
• The Effects Of Omega-3 Polyunsaturated Fatty Acids On Pancreatic Cancer And Pancreatic Stellate Cells In Vitro

  2019cites this paper
• Anorexie-Kachexie-Syndrom

  2019cites this paper
• Nutritional issues in patients with cancer

  2019cites this paper
• Associations between Omega-3 Fatty Acid Supplementation and Anti-Inflammatory Effects in Patients with Digestive System Cancer: A Meta-Analysis

  2019cites this paper
• Nutrition and Cachexia in Gastrointestinal Cancer Patients

  2019cites this paper
• Use and effects of oral nutritional supplements in patients with cancer.

  2019cites this paper
• Effects of acute oral feeding on protein metabolism and muscle protein synthesis in individuals with cancer.

  2019cites this paper
• Cancer-Associated Muscle Dysfunction

  2019cites this paper
• Cachexia / Anorexia and Feeding Difficulties

  2018influential citation
• Cancer cachexia: rationale for the MENAC (Multimodal—Exercise, Nutrition and Anti-inflammatory medication for Cachexia) trial

  2018cites this paper
• Protective and Restorative Effects of Nutrients and Phytochemicals

  2018cites this paper
• A window beneath the skin: how computed tomography assessment of body composition can assist in the identification of hidden wasting conditions in oncology that profoundly impact outcomes

  2018cites this paper
• Effect of Eicosapentaenoic Acid on Body Composition and Inflammation Markers in Patients with Head and Neck Squamous Cell Cancer from a Public Hospital in Mexico

  2018cites this paper
• Should omega-3 fatty acids be used for adjuvant treatment of cancer cachexia?

  2018cites this paper
• Systematic review and meta-analysis of the evidence for oral nutritional intervention on nutritional and clinical outcomes during chemo(radio)therapy: current evidence and guidance for design of future trials

  2018cites this paper
• Cancer cachexia: Diagnosis, assessment, and treatment.

  2018cites this paper
• Lung Cancer Cachexia: Can Molecular Understanding Guide Clinical Management?

  2018cites this paper
• Genetic influence of cytokine polymorphisms on the clinical outcome of Japanese gastrointestinal cancer patients in palliative care.

  2018cites this paper
• Caloric restriction is associated with preservation of muscle strength in experimental cancer cachexia

  2018cites this paper
• Title: A novel multimodal treatment strategy for cancer cachexia; rationale and motivation for the MENAC (Multimodal – Exercise, Nutrition and Anti-inflammatory medication for Cachexia) trial

  2018cites this paper
• Mangelernährung in der Onkologie. Ursachen, Folgen und Bedeutung der Ernährungstherapie

  2018cites this paper
• Prävention und Behandlung der Kachexie

  2017cites this paper
• Open Access book publisher

  2017cites this paper
• Comprehensive Approach to Sarcopenia and Cachexia Treatment

  2017cites this paper
• ESPEN guidelines on nutrition in cancer patients.

  2017cites this paper
• Lipid remodelling and an altered membrane associated proteome may drive the 1 differential effects of EPA and DHA treatment on skeletal muscle glucose uptake and 2 protein accretion 3

  2017cites this paper
• Physical performance and muscle mass in the assessment of sarcopenia and its association with receipt and completion of planned treatment in non-small cell lung cancer

  2017cites this paper
• Novel targeted therapies for cancer cachexia.

  2017cites this paper
• Cancer Cachexia: Cause, Diagnosis, and Treatment.

  2017cites this paper
• Ernährungsmedizinische Aspekte in der Palliativversorgung

  2017cites this paper
• Rôle de médiateurs de l'inflammation dans l'altération de la fonction musculaire : étude des effets du sepsis et de la chimiothérapie sur un modèle murin

  2017cites this paper
• Omega-3 Fatty Acids in Patients with Anorexia-Cachexia Syndrome Associated with Malignancy and Its Treatments.

  2017cites this paper
• Nutrition in cachexia: from bench to bedside

  2016cites this paper
• A systematic review on the role of vitamins, minerals, proteins, and other supplements for the treatment of cachexia in cancer: a European Palliative Care Research Centre cachexia project

  2016influential citation
• Gaps in nutritional research among older adults with cancer.

  2016cites this paper
• Does nutrition support have a role in managing cancer cachexia?

  2016cites this paper
• 4-Hydroxyhexenal and 4-hydroxynonenal are mediators of the anti-cachectic effect of n-3 and n-6 polyunsaturated fatty acids on human lung cancer cells.

  2016cites this paper
• Prävention und Behandlung der Kachexie

  2016cites this paper
• Cancer-associated malnutrition, cachexia and sarcopenia: the skeleton in the hospital closet 40 years later

  2016cites this paper
• [Prevention and treatment of cachexia : Exercise and nutritional therapy].

  2016cites this paper
• Effects of nutritional intervention in head and neck cancer patients undergoing radiotherapy: A prospective randomized clinical trial.

  2016cites this paper
• Omega-3 Fatty Acids in Cancer: Insight into the Mechanism of Actions in Preclinical Cancer Models

  2016cites this paper
• Cachexia in patients with oesophageal cancer

  2016cites this paper
• Current and future care of patients with the cancer anorexia-cachexia syndrome.

  2015cites this paper
• Nutritional approaches in cancer: relevance of individualized counseling and supplementation.

  2015cites this paper
• IMPORTANT BIOACTIVE PROPERTIES OF OMEGA-3 FATTY ACIDS

  2015cites this paper
• Cachexia: a preventable comorbidity of cancer. A T.A.R.G.E.T. approach.

  2015cites this paper
• Omega-3 polyunsaturated fatty acids and cancer: lessons learned from clinical trials

  2015cites this paper
• Echium plantagineum (echium) does not prevent weight loss in head and neck cancer patients

  2015cites this paper
• Nutrition therapy in cachectic cancer patients. The Tight Caloric Control (TiCaCo) pilot trial.

  2015cites this paper
• Nutritional considerations for the palliative care patient.

  2015cites this paper
• Fish oil in cancer cachexia.

  2015cites this paper
• Important bioactive properties of omega-3 fatty acids

  2015cites this paper
• Role of n-3 fatty acids in muscle loss and myosteatosis.

  2014cites this paper
• Cancer cachexia: an unmet need in cancer treatment

  2014cites this paper
• Evidence Based Review of Fish Oil: Going Beyond the Headlines

  2014cites this paper
• Omega-3 fatty acids and protein metabolism: enhancement of anabolic interventions for sarcopenia

  2014cites this paper
• Ernährungstherapie bei Kachexie und Sarkopenie

  2014cites this paper
• Creatine, L-Carnitine, and ω3 Polyunsaturated Fatty Acid Supplementation from Healthy to Diseased Skeletal Muscle

  2014cites this paper
• In Reply

  2014cites this paper
• Comprehensive approach to sarcopenia treatment.

  2014cites this paper
• Anticolorectal cancer activity of the omega-3 polyunsaturated fatty acid eicosapentaenoic acid

  2014cites this paper
• Cachexia and pancreatic cancer: are there treatment options?

  2014cites this paper